01 1Sichuan Xieli Pharmaceutical
01 1GEFITINIB
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-05
Pay. Date : 2015-12-23
DMF Number : 26456
Submission : 2012-09-18
Status : Active
Type : II
20
Sichuan Xieli Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GEFITINIB, with a corresponding US DMF Number 26456.
Remarkably, this DMF maintains an Active status since its submission on September 18, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 05, 2016, and payment made on December 23, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
